CDX2 Antibody (rCDX2/1690) [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-08737PCP
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Immunohistochemistry-Paraffin
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 kappa Clone # rCDX2/1690
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CDX2 Antibody (rCDX2/1690) [PerCP]
Immunogen
Recombinant fragment (around aa150-249) of human CDX2 protein (exact sequence is proprietary) (Uniprot: Q99626)
Localization
Nuclear
Marker
GI Epithelial Marker
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for CDX2 Antibody (rCDX2/1690) [PerCP]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CDX2
Long Name
Caudal-type Homeobox Transcription Factor 2
Alternate Names
CDX3
Gene Symbol
CDX2
Additional CDX2 Products
Product Documents for CDX2 Antibody (rCDX2/1690) [PerCP]
Product Specific Notices for CDX2 Antibody (rCDX2/1690) [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...